Lisaftoclax, also known as APG-2575, is a small-molecule selective inhibitor of the B-cell lymphoma 2 protein, commonly known as BCL-2. It belongs to the class of targeted antineoplastic research compounds associated with apoptosis regulation and hematological malignancy drug development.
Lisaftoclax selectively targets the anti-apoptotic BCL-2 protein. Inhibition of BCL-2 is associated with restoration of the normal programmed cell death process, known as apoptosis, in susceptible cancer cells.
Lisaftoclax is associated with pharmaceutical and oncology research involving chronic lymphocytic leukemia, small lymphocytic lymphoma, and other hematological malignancies. It is used in specialized pharmaceutical research, analytical development, formulation studies, and targeted therapy development programs.
Lisaftoclax API requires stringent control of identity, assay, purity, related substances, residual solvents, elemental impurities, and other critical quality parameters. Validated analytical methods are important for ensuring consistent product quality and specification compliance.
Swapnroop Drugs and Pharmaceuticals supports Lisaftoclax API sourcing and specialized pharmaceutical raw material requirements for pharmaceutical companies, oncology research organizations, formulation developers, laboratories, and international buyers. Product specifications and documentation are supplied according to applicable customer and project requirements.
Lisaftoclax API is associated with:
Available documentation may include, subject to product and supply requirements:
Certificate of Analysis – COA
Material Safety Data Sheet – MSDS / SDS
Product Specification Sheet
Analytical Test Report
HPLC Purity Data, where available
Mass Spectrometry Data, where available
Residual Solvent Information
Elemental Impurity Information, where applicable
Storage and Handling Information
Stability Information, where available
Regulatory and technical documentation, subject to agreement
Swapnroop Drugs and Pharmaceuticals is a pharmaceutical raw material supplier based in Maharashtra, India, serving pharmaceutical, research, and development requirements.
We focus on:
Swapnroop Drugs and Pharmaceuticals supplies and supports Lisaftoclax API requirements for pharmaceutical companies, oncology research organizations, formulation developers, laboratories, and international buyers.
For Lisaftoclax API requirements, customers may contact our team for product availability, specifications, documentation, quantity, packaging, storage conditions, and commercial information.
Company Name: Swapnroop Drugs and Pharmaceuticals
Location: Maharashtra, India
Email: enquiry@sdp.org.in
Website: www.sdp.org.in